REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Mevak A.S. (Slovakia)

Main Activities: Real Estate
Full name: Mevak A.S. Profile Updated: October 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Mevak a.s is a joint-stock company in the veterinary industry, specializing in the manufacturing of products for prevention and therapy. The company offers inoculation substances, curative pharmaceutical preparations, and medical aids.

Headquarters
Biovetska, 32
Nitra; Nitriansky; Postal Code: 94905

Contact Details: Purchase the Mevak A.S. report to view the information.

Website: http://www.mevak.sk

Basic Information
Total Employees:
Purchase the Mevak A.S. report to view the information.
Outstanding Shares:
Purchase the Mevak A.S. report to view the information.
Registered Capital:
Purchase the Mevak A.S. report to view the information.
Financial Auditors:
Purchase the Mevak A.S. report to view the information.
Incorporation Date:
May 01, 1992
Key Executives
Purchase this report to view the information.
Chairman of the Board
Purchase this report to view the information.
Vice-chair of the Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after Mevak A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
21.79%▲
Total operating revenue
23.28%▲
Operating profit (EBIT)
3.2%▲
EBITDA
19.2%▲
Net Profit (Loss) for the Period
2.94%▲
Total assets
-2.49%▼
Total equity
-6.35%▼
Operating Profit Margin (ROS)
8.22%▲
Net Profit Margin
8.73%▲
Return on Equity (ROE)
-0.24%▼
Debt to Equity Ratio
0.64%▲
Quick Ratio
-0.01%▼
Cash Ratio
-0.01%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo